TIMP2 and neoplasm: Studies have demonstrated that the overexpression of TIMP-2 inhibits tumor growth and angiogenesis by the upregulation of MAP kinase phosphatase 1, which dephosphorylates p38 MAPK, a molecule involved in the proliferation and migration of endothelial cells [380].